AMGN
Amgen Inc. · Healthcare · Drug Manufacturers - General
TECHNeutralZACKSHold
R500#425 today
$403.04
-1.04% today · -2.79% 1W
Oct 2 close or latest
PreviewWhy it's moving
Underperforming without a clear catalyst yet
- AMGN −1.04% on the last session vs SPY +0.74%: −1.8 pts of stock-specific move.
- Aftermath, big drop (Oct 1): After its 72 big drops in the past 5 years, AMGN typically gained 0.8% over the next month (median) and was higher 56% of the time; half the outcomes fell between -3.8% and +6.3%. An ordinary month: +0.9%. Among S&P 500 stocks after big drops, that ranks #393 of 500.
- 1 insider or congressional trade in the past 30 days.
- Market backdrop (Fri): Average Hourly Earnings m/m 0.1% vs 0.3% expected (cooler); Non-Farm Employment Change 29K vs 89K expected (weaker); S&P futures +0.41%, 10-year yield -5bp in the 30 minutes after.
Assembled from Wallsti's own signals.
Key facts
- Market cap
- $217.9B
- Held by institutions
- 85.0%
- Short interest
- 2.6%
- 52-week range
- 288.00–447.03
- Analyst mean target
- —
- Next earnings
- Nov 3 est.
- Forward P/E
- 16.5
Recent events
Earnings ▲
2Q2026 results: EPS $6.29 vs $5.62 expected beat +$0.67 (+12.0%); next session +4.6% (+4.8 vs SPY)Earnings ▲
1Q2026 results: EPS $5.15 vs $4.77 expected beat +$0.38 (+8.0%); revenue $8.6B; next session -4.8% (-5.0 vs SPY)